Anhui Liuguo Chemical Co., Ltd. (SHA:600470)
China · Delayed Price · Currency is CNY 6.59
+0.23 (3.62%)
Feb 6, 2026, 3:00 PM CST
Anhui Liuguo Chemical Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 6,194 | 6,006 | 6,588 | 7,293 | 5,579 | 4,440 |
Other Revenue | 245.27 | 245.27 | 344.74 | 257.16 | 405.61 | 383.34 |
| 6,439 | 6,251 | 6,933 | 7,550 | 5,985 | 4,823 | |
Revenue Growth (YoY) | -0.73% | -9.83% | -8.17% | 26.16% | 24.08% | 10.79% |
Cost of Revenue | 6,074 | 5,697 | 6,396 | 6,742 | 5,121 | 4,187 |
Gross Profit | 364.51 | 554.16 | 536.83 | 808.32 | 863.07 | 636.14 |
Selling, General & Admin | 278.6 | 278.92 | 273.26 | 309.36 | 380.04 | 274.36 |
Research & Development | 213.3 | 206.05 | 200.42 | 199.86 | 157.27 | 122.7 |
Other Operating Expenses | 24.39 | 30.71 | 29.85 | 34.32 | 40.72 | 19.22 |
Operating Expenses | 512.92 | 516.25 | 509.78 | 545.4 | 584.17 | 417.75 |
Operating Income | -148.41 | 37.91 | 27.05 | 262.92 | 278.9 | 218.39 |
Interest Expense | -52.89 | -65.43 | -65.11 | -66.61 | -57.94 | -76.52 |
Interest & Investment Income | 39.07 | 35.57 | 71.22 | 17.95 | 14.48 | 5.15 |
Earnings From Equity Investments | - | - | - | - | 1.56 | 1.63 |
Currency Exchange Gain (Loss) | 8.46 | 8.46 | 6.52 | 1.65 | 1.24 | -1.1 |
Other Non Operating Income (Expenses) | -9.96 | -1.14 | 6.58 | 35.63 | -1.47 | 6.41 |
EBT Excluding Unusual Items | -163.73 | 15.36 | 46.26 | 251.53 | 236.78 | 153.97 |
Gain (Loss) on Sale of Assets | -0.93 | -0.73 | -3.45 | -0.51 | 16.48 | 14.72 |
Asset Writedown | -51.63 | - | - | -4.44 | - | - |
Other Unusual Items | 50.93 | 50.93 | 22.59 | 31.89 | 52.42 | 19.77 |
Pretax Income | -165.35 | 65.57 | 65.4 | 278.47 | 305.68 | 188.46 |
Income Tax Expense | 1.99 | -1.65 | 13.11 | 4.79 | -14.13 | 5.6 |
Earnings From Continuing Operations | -167.34 | 67.22 | 52.29 | 273.68 | 319.81 | 182.86 |
Net Income to Company | -167.34 | 67.22 | 52.29 | 273.68 | 319.81 | 182.86 |
Minority Interest in Earnings | -53.16 | -42.04 | -29.53 | -82.51 | -82.52 | -14.88 |
Net Income | -220.5 | 25.18 | 22.75 | 191.17 | 237.29 | 167.98 |
Net Income to Common | -220.5 | 25.18 | 22.75 | 191.17 | 237.29 | 167.98 |
Net Income Growth | - | 10.65% | -88.10% | -19.44% | 41.26% | - |
Shares Outstanding (Basic) | 481 | 504 | 569 | 517 | 527 | 525 |
Shares Outstanding (Diluted) | 481 | 504 | 569 | 517 | 527 | 525 |
Shares Change (YoY) | -12.80% | -11.48% | 10.09% | -2.02% | 0.45% | 0.18% |
EPS (Basic) | -0.46 | 0.05 | 0.04 | 0.37 | 0.45 | 0.32 |
EPS (Diluted) | -0.46 | 0.05 | 0.04 | 0.37 | 0.45 | 0.32 |
EPS Growth | - | 25.00% | -89.19% | -17.78% | 40.63% | - |
Free Cash Flow | -847 | -51.16 | -139.56 | 130.39 | 313.93 | 66.8 |
Free Cash Flow Per Share | -1.76 | -0.10 | -0.24 | 0.25 | 0.59 | 0.13 |
Gross Margin | 5.66% | 8.87% | 7.74% | 10.71% | 14.42% | 13.19% |
Operating Margin | -2.31% | 0.61% | 0.39% | 3.48% | 4.66% | 4.53% |
Profit Margin | -3.43% | 0.40% | 0.33% | 2.53% | 3.96% | 3.48% |
Free Cash Flow Margin | -13.15% | -0.82% | -2.01% | 1.73% | 5.25% | 1.39% |
EBITDA | 89.48 | 275.89 | 265.14 | 556.74 | 565.9 | 502.8 |
EBITDA Margin | 1.39% | 4.41% | 3.82% | 7.37% | 9.46% | 10.42% |
D&A For EBITDA | 237.89 | 237.98 | 238.09 | 293.82 | 287 | 284.41 |
EBIT | -148.41 | 37.91 | 27.05 | 262.92 | 278.9 | 218.39 |
EBIT Margin | -2.31% | 0.61% | 0.39% | 3.48% | 4.66% | 4.53% |
Effective Tax Rate | - | - | 20.05% | 1.72% | - | 2.97% |
Revenue as Reported | 6,439 | 6,251 | 6,933 | 7,550 | 5,985 | 4,823 |
Advertising Expenses | - | 3.02 | 4.01 | 1.26 | 4.81 | 6 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.